286 related articles for article (PubMed ID: 9140565)
1. Oncotic, hemodilutional, and hemostatic effects of isotonic saline and hydroxyethyl starch solutions in clinically normal ponies.
Jones PA; Tomasic M; Gentry PA
Am J Vet Res; 1997 May; 58(5):541-8. PubMed ID: 9140565
[TBL] [Abstract][Full Text] [Related]
2. Effects of 6% hetastarch (600/0.75) or lactated Ringer's solution on hemostatic variables and clinical bleeding in healthy dogs anesthetized for orthopedic surgery.
Chohan AS; Greene SA; Grubb TL; Keegan RD; Wills TB; Martinez SA
Vet Anaesth Analg; 2011 Mar; 38(2):94-105. PubMed ID: 21303440
[TBL] [Abstract][Full Text] [Related]
3. Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery.
Schroth M; Plank C; Meissner U; Eberle KP; Weyand M; Cesnjevar R; Dötsch J; Rascher W
Pediatrics; 2006 Jul; 118(1):e76-84. PubMed ID: 16751617
[TBL] [Abstract][Full Text] [Related]
4. The hemostatic profiles of patients with Type O and non-O blood after acute normovolemic hemodilution with 6% hydroxyethyl starch (130/0.4).
Kang JG; Ahn HJ; Kim GS; Hahm TS; Lee JJ; Gwak MS; Choi SJ
Anesth Analg; 2006 Dec; 103(6):1543-8. PubMed ID: 17122237
[TBL] [Abstract][Full Text] [Related]
5. Effect of hydroxyethyl starch solution in normal horses and horses with colic or acute colitis.
Schusser GF; Rieckhoff K; Ungemach FR; Huskamp NH; Scheidemann W
J Vet Med A Physiol Pathol Clin Med; 2007 Dec; 54(10):592-8. PubMed ID: 18045345
[TBL] [Abstract][Full Text] [Related]
6. [Changes in blood coagulation in treatment with hydroxyethyl starch].
Sefrin P; Rauch S; Zieglmeyer C
Anaesthesiol Reanim; 1998; 23(6):149-56. PubMed ID: 10036794
[TBL] [Abstract][Full Text] [Related]
7. A comparison of the effects of a 4% modified fluid gelatin and a 6% hydroxyethyl starch on haemodilution, colloid osmotic pressure, haemostasis and renal parameters in healthy ponies.
Gratwick Z; Viljoen A; Page PC; Goddard A; Fosgate GT; Lyle CH
Equine Vet J; 2017 May; 49(3):363-368. PubMed ID: 27258662
[TBL] [Abstract][Full Text] [Related]
8. Hemostatic defects associated with two infusion rates of dextran 70 in dogs.
Concannon KT; Haskins SC; Feldman BF
Am J Vet Res; 1992 Aug; 53(8):1369-75. PubMed ID: 1380787
[TBL] [Abstract][Full Text] [Related]
9. A randomized, blinded trial comparing the hemostatic effects of pentastarch versus hetastarch.
Strauss RG; Pennell BJ; Stump DC
Transfusion; 2002 Jan; 42(1):27-36. PubMed ID: 11896309
[TBL] [Abstract][Full Text] [Related]
10. Effects of oxypolygelatin and dextran 70 on hemostatic variables in dogs.
Glowaski MM; Moon-Massat PF; Erb HN; Barr SC
Vet Anaesth Analg; 2003 Oct; 30(4):202-10. PubMed ID: 12925177
[TBL] [Abstract][Full Text] [Related]
11. Decreased circulating levels of von Willebrand factor after intravenous administration of a rapidly degradable hydroxyethyl starch (HES 200/0.5/6) in healthy human subjects.
de Jonge E; Levi M; Büller HR; Berends F; Kesecioglu J
Intensive Care Med; 2001 Nov; 27(11):1825-9. PubMed ID: 11810130
[TBL] [Abstract][Full Text] [Related]
12. The effects of desmopressin on hemostatic parameters in the normal dog.
Johnstone IB; Crane S
Can J Vet Res; 1986 Apr; 50(2):265-71. PubMed ID: 3093039
[TBL] [Abstract][Full Text] [Related]
13. [Accumulation of two different hydroxyethyl starch preparations in the placenta after hemodilution in patients with fetal intrauterine growth retardation or pregnancy hypertension].
Heilmann L; Lorch E; Hojnacki B; Müntefering H; Förster H
Infusionstherapie; 1991 Oct; 18(5):236-43. PubMed ID: 1722779
[TBL] [Abstract][Full Text] [Related]
14. [Effect of a new 10% hydroxyethyl starch solution HES/270/0.5 on blood coagulation, blood loss and hemodynamics in comparison with 3.5% PPL].
Penner M; Fingerhut D; Tacke A
Infusionstherapie; 1990 Dec; 17(6):314-8. PubMed ID: 1709146
[TBL] [Abstract][Full Text] [Related]
15. Effects of acute hypervolemic fluid infusion of hydroxyethyl starch and gelatin on hemostasis and possible mechanisms.
Jin SL; Yu BW
Clin Appl Thromb Hemost; 2010 Feb; 16(1):91-8. PubMed ID: 19825916
[TBL] [Abstract][Full Text] [Related]
16. [The maximum safe dosage of the low molecular weight hydroxyethyl starch, HESPANDAR (HES), estimated from HES induced changes in coagulation parameters and clinical bleeding].
Saito Y; Uchida K; Yamamoto H; Ichiishi N; Matsushita F
Masui; 1999 Mar; 48(3):238-43. PubMed ID: 10214006
[TBL] [Abstract][Full Text] [Related]
17. Acquired von Willebrand syndromes: clinical features, aetiology, pathophysiology, classification and management.
Michiels JJ; Budde U; van der Planken M; van Vliet HH; Schroyens W; Berneman Z
Best Pract Res Clin Haematol; 2001 Jun; 14(2):401-36. PubMed ID: 11686107
[TBL] [Abstract][Full Text] [Related]
18. [Comparison of 5% human albumin and 6% 200/0.5 HES as exclusive colloid components in large surgical interventions].
Vogt N; Bothner U; Georgieff M
Anasthesiol Intensivmed Notfallmed Schmerzther; 1994 May; 29(3):150-6. PubMed ID: 7519062
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the pharmacokinetics of two von Willebrand factor concentrates [Biostate and AHF (High Purity)] in people with von Willebrand disorder. A randomised cross-over, multi-centre study.
Favaloro EJ; Lloyd J; Rowell J; Baker R; Rickard K; Kershaw G; Street A; Scarff K; Barrese G; Maher D; McLachlan AJ
Thromb Haemost; 2007 Jun; 97(6):922-30. PubMed ID: 17549293
[TBL] [Abstract][Full Text] [Related]
20. A prospective study of G-CSF effects on hemostasis in allogeneic blood stem cell donors.
LeBlanc R; Roy J; Demers C; Vu L; Cantin G
Bone Marrow Transplant; 1999 May; 23(10):991-6. PubMed ID: 10373063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
